Pharmafile - Research and Development News
The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in development at British American...
Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) drug candidates within...
The partnership aims to enrich Envision Pharma Group’s global reach in medical affairs, including strategic publications planning and delivery,...
Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy and pipeline”....
The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults.
Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the financial conditions created by the coronavirus.
Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the former’s therapeutics in a...
Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has financial links...
Incyte has lifted the curtain on promising new Phase 3 data for its 0.75% and 1.5% twice daily cream formulations of ruxolitinib in the treatment of...
COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has selected a candidate...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
